Literature DB >> 9778604

A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century.

R M Post1, K D Denicoff, M A Frye, R T Dunn, G S Leverich, E Osuch, A Speer.   

Abstract

Anticonvulsants have moved into an important position as alternatives and adjuncts to lithium carbonate in the treatment of bipolar illness. Work with the nonhomologous model of kindled seizures helped in the choice of carbamazepine as a potential mood stabilizer and in the study of the mechanisms of action of the second generation anticonvulsants carbamazepine and valproate, as well as the putative third generation psychotropic anticonvulsants lamotrigine and gabapentin. Anticonvulsant neuropeptides such as TRH and nonconvulsant approaches with repeated transcranial magnetic stimulation (rTMS) also appear promising.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778604     DOI: 10.1159/000026532

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  14 in total

1.  Are clozapine blood dyscrasias associated with concomitant medications?

Authors:  Tammie Lee Demler; Eileen Trigoboff
Journal:  Innov Clin Neurosci       Date:  2011-04

2.  BALANCE: a large simple trial of maintenance treatment for bipolar disorder.

Authors:  John R Geddes; Jennifer M Rendell; Guy M Goodwin
Journal:  World Psychiatry       Date:  2002-02       Impact factor: 49.548

3.  Mood stabilizer psychopharmacology.

Authors:  Todd D Gould; Guang Chen; Husseini K Manji
Journal:  Clin Neurosci Res       Date:  2002-11-14

4.  Elevated endogenous GABA concentration attenuates glutamate-glutamine cycling between neurons and astroglia.

Authors:  Jehoon Yang; Jun Shen
Journal:  J Neural Transm (Vienna)       Date:  2009-01-30       Impact factor: 3.575

5.  Adolecsent mania, EEG abnormality and response to anticonvulsants: a three - year follow-up study.

Authors:  T K Aich; V K Sinha; H S Nizami
Journal:  Indian J Psychiatry       Date:  2001-07       Impact factor: 1.759

Review 6.  Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection.

Authors:  Xiaohua Li; Gautam N Bijur; Richard S Jope
Journal:  Bipolar Disord       Date:  2002-04       Impact factor: 6.744

Review 7.  Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy.

Authors:  Kathryn J Macdonald; L Trevor Young
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

8.  Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium.

Authors:  Hubertus Himmerich; Dagmar Koethe; Andreas Schuld; Alexander Yassouridis; Thomas Pollmächer
Journal:  Psychopharmacology (Berl)       Date:  2004-11-25       Impact factor: 4.530

9.  Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin; P M Haddad; I N Ferrier; J K Aronson; Trh Barnes; A Cipriani; D R Coghill; S Fazel; J R Geddes; H Grunze; E A Holmes; O Howes; S Hudson; N Hunt; I Jones; I C Macmillan; H McAllister-Williams; D R Miklowitz; R Morriss; M Munafò; C Paton; B J Saharkian; Kea Saunders; Jma Sinclair; D Taylor; E Vieta; A H Young
Journal:  J Psychopharmacol       Date:  2016-03-15       Impact factor: 4.153

Review 10.  Transcranial magnetic stimulation for treating depression.

Authors:  J L Martin; M J Barbanoj; T E Schlaepfer; S Clos; V Perez; J Kulisevsky; A Gironell
Journal:  Cochrane Database Syst Rev       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.